Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,666 | 11,367 | 12,253 | 8,734 | 9,068 |
| Marketable Securities | 6,017 | 3 | 78 | 113 | 344 |
| Other current assets | 67 | 66 | 0 | 0 | 0 |
| TOTAL | $10,955 | $11,572 | $12,912 | $8,947 | $9,618 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 69 | 71 | 137 | 97 | 98 |
| TOTAL | $69 | $71 | $137 | $97 | $98 |
| Total Assets | $11,024 | $11,643 | $13,049 | $9,045 | $9,716 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 660 | 364 | 240 | 197 | 221 |
| TOTAL | $732 | $436 | $312 | $269 | $293 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 72 | 72 | 72 | 72 | 72 |
| TOTAL | $848 | $866 | $884 | $902 | $920 |
| Total Liabilities | $1,580 | $1,302 | $1,196 | $1,171 | $1,213 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,159 | 3,159 | 3,139 | 99,395 | 99,395 |
| Common Shares | 0 | 0 | 0 | 10 | 10 |
| Retained earnings | -8,078 | -7,171 | -5,508 | -4,525 | -3,867 |
| Other shareholders' equity | 5 | 0 | 0 | 0 | -50 |
| TOTAL | $9,444 | $10,341 | $11,853 | $7,874 | $8,503 |
| Total Liabilities And Equity | $11,024 | $11,643 | $13,049 | $9,045 | $9,716 |